Could deeper muscle relaxation during hysterectomy reduce pain and opioid use?
NCT ID NCT07485517
First seen Jun 24, 2026 · Last updated Aug 14, 2026 · Updated 4 times
Summary
This study will compare deep versus moderate muscle relaxation during open hysterectomy in 88 women. Researchers want to see if deeper relaxation reduces pain, the need for opioid painkillers, and inflammation after surgery. The goal is to find the best approach to improve recovery and comfort.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- rocuronium bromide
- What this could lead to
- If it works, this could help doctors choose the best level of muscle relaxation during surgery to reduce pain and opioid use.
- What could go wrong
- This is a small, early-stage study with only 88 participants, so results may not apply to all patients. It measures temporary effects, not long-term outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 88 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women who will be admitted to undergo elective hysterectomy ,-ASA grade I or II, * Body mass index (BMI) of \<35 kg/m2 Exclusion Criteria: hemoglobin concentration of ≤7 gm%, * the presence of neuromuscular disorders * uncontrolled medical diseases * autoimmune diseases, maintenance on immunosuppressant therapy for any indication * refusal to sign the written consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Change in serum levels of the estimated inflammatory cytokines are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Faculty of Medicine Menoufia University
RECRUITINGMenoufia, Eg.mn, 32511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.